KLRS Financials

Kalaris Therapeutics Inc - Financial statements & key metrics

Stock Price

$6.32

Market Cap

$144.91M

EPS

$-2.85

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-58.77M

EPS (Diluted)

$-11.73

Balance Sheet Highlights

Total Assets

$118.55M

Total Liabilities

$5.24M

Shareholders Equity

Cash & Equivalents

$118.29M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-67.70M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-3.1%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is KLRS revenue?

View KLRS's income statement for detailed revenue data.

Is KLRS profitable?

KLRS reported a loss of $58.77M in the most recent quarter.

What is KLRS market cap?

KLRS has a market capitalization of $144.91M, making it a small-cap stock.

Does KLRS have debt?

View KLRS's balance sheet for debt information.

What is KLRS cash flow?

Cash flow data is available in the full financial statements.